Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P33527 (
ABCC1
)
1,164
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Multidrug resistance-associated protein 1
(
MRP1
) plays a protective role in the etiology and progression of chronic obstructive pulmonary disease (COPD) which results from oxidative stress and inflammation of lung injury. The lower functional
MRP1
activity is related to COPD development. Our previous study showed that Allyl isothiocyanate (AITC) induced the expression and activity of
MRP1
in a dose-dependent manner. However, which signaling pathway contributes to the upregulation of
MRP1
by AITC is unclear. In this study, signaling pathway specific inhibitors were used to examine the mechanism of AITC. We found that
JNK
inhibitor SP600125 treatment decreased
MRP1
mRNA expression in 16HBE14o- cells. But the ERK inhibitor U0126 or PI3K/Akt inhibitor LY294002 produced no obvious effect. The AITC-induced increase of
MRP1
mRNA expression was abolished by cotreatment of SP600125, while it was not obviously affected by U0126 or LY294002. Furthermore, AITC acivates the
JNK
signaling pathway in 16HBE14o- cells. Finally, we found that
JNK
pathway mediated the upregulation of AITC-induced expression and function of
MRP1
. Taken together, our results indicated that AITC increased the expression and the activity of
MRP1
via a
JNK
-dependent pathway. ERK and PI3K signaling pathway were not involved in the expression of
MRP1
mRNA.
...
PMID:Upregulation of Multidrug Resistance-Associated Protein 1 by Allyl Isothiocyanate in Human Bronchial Epithelial Cell: Involvement of c-Jun N-Terminal Kinase Signaling Pathway. 2627 26